QIAGEN N.V. is a renowned multinational provider of sample and assay technologies for various sectors including molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company’s recent achievements and market presence reflect its significant contribution to the field of biotechnology. With the molecular diagnostics market projected to reach USD 33.7 billion by 2032, QIAGEN’s strategic positioning and innovative solutions position it as a key player in this rapidly evolving industry.
Tags: None
Read more from search.yahoo.com